Primary ciliary dyskinesia (PCD) is a rare genetic disorder in which the tiny hair-like structures called cilia that line the airways, reproductive tract, and other organs either beat abnormally or don’t move at all. Because cilia are responsible for sweeping mucus out of the lungs, establishing the left-right positioning of organs during embryonic development, and moving eggs through the fallopian tubes, a defect in these structures causes a surprisingly wide range of problems: chronic lung infections from birth, sinuses that never fully clear, ears prone to persistent fluid buildup, and in roughly half of affected people, internal organs arranged in mirror image. The condition is inherited, under-recognized, and often diagnosed years after symptoms begin.
What Cilia Do and Why They Matter
Cilia are microscopic, whip-like projections found on the surface of cells throughout the body. In the airways, millions of them beat in coordinated waves to push a thin blanket of mucus upward and out, trapping inhaled dust, bacteria, and viruses along the way. This conveyor-belt system is called mucociliary clearance, and it is the lungs’ primary self-cleaning mechanism. Each cilium contains an internal scaffold called the axoneme, made up of nine pairs of protein tubes arranged in a ring, with motor proteins called dyneins that power the beating motion.1PubMed Central. Axoneme Structure from Motile Cilia When any part of that internal machinery is built incorrectly, the cilia either freeze in place, beat weakly, or move in an uncoordinated way, and the mucus just sits there.
This isn’t limited to the lungs. Motile cilia also line the middle ear, the sinuses, the brain’s ventricles, the fallopian tubes, and the efferent ducts of the testes. The same structural defect that stalls mucus clearance in the chest can cause fluid buildup in the ears, reduced fertility, and even problems with cerebrospinal fluid flow. That multi-organ reach is what makes PCD so distinctive and so easy to misdiagnose when a clinician is only looking at one symptom at a time.
Genetic Roots
PCD is overwhelmingly inherited in an autosomal recessive pattern, meaning a child needs to receive a defective copy of the same gene from both parents to develop the condition.2PubMed Central. Primary ciliary dyskinesia: mechanisms and management Because carriers (people with only one defective copy) have no symptoms, the disorder often appears without any family history. Two of the most commonly mutated genes are DNAI1 and DNAH5, both of which encode parts of the dynein motor complex.3PubMed. Genetic causes of bronchiectasis: primary ciliary dyskinesia But PCD is genetically diverse: mutations in more than 50 different genes have been linked to the condition so far, each affecting a different piece of the ciliary architecture. Some knock out the outer dynein arms, some affect the inner arms, some disrupt the central pair of microtubules, and some interfere with the assembly process that builds cilia in the first place.4PubMed Central. Primary ciliary dyskinesia: a case report of double DNAH11 mutant alleles
This genetic variety is one reason diagnosis is difficult. There is no single gene test that catches every case. Researchers have even traced insights about human ciliary genes back to a single-celled green alga, Chlamydomonas, whose two flagella use the same dynein machinery. Families with PCD caused by mutations in the human version of a Chlamydomonas gene called ODA7 were identified through that cross-species detective work.5American Journal of Human Genetics. Loss-of-Function Mutations in the Human Ortholog of Chlamydomonas reinhardtii ODA7 Disrupt Dynein Arm Assembly and Cause Primary Ciliary Dyskinesia The evolutionary conservation of ciliary proteins means that what scientists learn from algae and mice frequently translates directly to human disease.
Situs Inversus and the Embryonic Node
One of the most striking features of PCD is that about half of people with the condition have situs inversus: their heart sits on the right side of the chest, their liver on the left, and the rest of their organs flipped like a mirror image. This seems bizarre until you understand that the left-right layout of the body is not hardwired genetically in the way you might assume. During early embryonic development, a small pit called the node contains cilia that spin in a circular motion, creating a leftward flow of fluid. That flow activates signaling molecules on one side of the embryo but not the other, triggering the asymmetric organ development that puts the heart on the left.6PubMed Central. Left–right asymmetry: cilia stir up new surprises in the node
When nodal cilia don’t work, that fluid flow never happens, and organ placement becomes essentially a coin flip. About half the time the organs end up in the normal arrangement by chance, and about half the time they’re reversed. A small fraction of PCD patients end up with heterotaxy, a more dangerous situation where some organs flip and others don’t, potentially leading to complex congenital heart defects. The combination of situs inversus with chronic sinusitis and bronchiectasis was first described as Kartagener syndrome in the 1930s, and for decades it was the only recognized presentation of what we now call PCD.
How the Condition Shows Up in Newborns and Children
PCD often makes its presence known within hours of birth. More than 80% of affected newborns develop unexplained respiratory distress, with mucus plugging causing patches of lung collapse even in full-term babies who have no other reason to struggle with breathing.7PubMed Central. Respiratory Distress in the Newborn with Primary Ciliary Dyskinesia Because neonatal respiratory distress has many causes, PCD is rarely the first thing clinicians consider. Red flags that should prompt investigation include a full-term baby needing supplemental oxygen for more than two days, lobar collapse on a chest X-ray, and the presence of situs inversus.8PubMed Central. Primary ciliary dyskinesia and neonatal respiratory distress
As children grow, the pattern becomes more recognizable. A persistent wet cough that never fully resolves, year-round nasal congestion and runny nose, and recurrent ear infections are the hallmarks. Many children with PCD are misdiagnosed with asthma, allergies, or recurrent pneumonia for years before anyone connects the dots. European registry data suggest that the diagnosed prevalence of PCD in children is roughly 3 to 7 per 100,000, though the true prevalence is likely higher because so many cases go unrecognized.9PubMed Central. Registries and collaborative studies for primary ciliary dyskinesia in Europe In adults the diagnosed prevalence drops even further, reflecting both underdiagnosis and diagnostic delay rather than the disease being rarer in grown-ups.
Ear, Nose, and Sinus Problems
Because the lining of the middle ear and sinuses relies on the same ciliated epithelium as the lungs, PCD hammers the upper respiratory tract from early childhood onward. Chronic otitis media with effusion, the persistent buildup of thick fluid behind the eardrum, is nearly universal in young children with PCD. This ongoing fluid retention causes conductive hearing loss that, while usually mild, can interfere with speech and language development during critical years.10PubMed. Hearing loss in children with primary ciliary dyskinesia Some children also develop sensorineural hearing loss, which is harder to explain and may reflect chronic inflammatory damage to the inner ear structures.
Sinus disease in PCD tends to be stubborn. Chronic rhinosinusitis develops early and persists into adulthood, often with nasal polyps. Nasal saline irrigation helps somewhat, and functional endoscopic sinus surgery can improve how well irrigations reach the sinus lining, but recurrence after surgery is common.11Journal of Otolaryngology-ENT Research. Nasal Polyposis in Patients with Primary Ciliary Dyskinesia In adults, imaging studies have found a high rate of mastoid bone condensation in PCD patients, which may be a congenital feature of the disease or a consequence of years of recurrent middle ear fluid.12PubMed Central. Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study Either way, it underscores how PCD affects the ears in ways that go beyond simple infections.
Fertility
The same dynein motors that drive airway cilia also power the tail of a sperm cell. Men with PCD frequently have immotile or poorly motile sperm, leading to subfertility or infertility. The degree varies depending on which gene is affected; some mutations leave sperm completely unable to swim, while others allow enough residual motility for natural conception in rare cases. Women with PCD can also face fertility challenges because cilia in the fallopian tubes normally help transport the egg toward the uterus, and cilia in the endometrium contribute to implantation. Limited evidence suggests that abnormal ciliary motion in both the fallopian tubes and the endometrium is the likely cause of reduced fertility in women with PCD.13PubMed Central. The impact of primary ciliary dyskinesia on female and male fertility: a narrative review That said, many women with PCD do become pregnant, sometimes without assisted reproduction, so infertility is not inevitable. For men with immotile sperm, intracytoplasmic sperm injection (ICSI) can bypass the motility problem entirely.
The Hydrocephalus Question
Ependymal cilia line the ventricles of the brain and help move cerebrospinal fluid. Because PCD affects motile cilia broadly, it’s natural to ask whether people with PCD are at risk for hydrocephalus, the dangerous buildup of fluid in the brain. In mice, knocking out ciliary genes reliably produces enlarged ventricles. But the picture in humans is more nuanced. Hydrocephalus is recognized as a possible complication of PCD, and specific gene mutations including MCIDAS, DNAH5, CCNO, and IFT46 have been identified in cases where both conditions overlap.14PubMed. Emerging insights into primary ciliary dyskinesia-associated hydrocephalus: a scoping review
However, hydrocephalus is uncommon among people with PCD compared with how reliably it appears in mouse models. A careful reassessment of the evidence argues that ependymal cilia may not be the primary driver of cerebrospinal fluid movement in the human brain, particularly during fetal development before those cilia have matured, and that some hydrocephalus cases linked to ciliary gene mutations may actually stem from altered brain development rather than stalled fluid flow.15PubMed. Rethinking the cilia hypothesis of hydrocephalus The bottom line for patients and families: hydrocephalus is something clinicians should be aware of in PCD, but it is far from a routine feature of the disease.
Getting a Diagnosis
Diagnosing PCD is notoriously difficult, which is why the average age at diagnosis has historically been in late childhood or even adulthood despite symptoms that begin at birth. No single test is definitive on its own, so diagnosis usually involves combining several lines of evidence.
The most accessible screening tool is nasal nitric oxide (nNO) measurement. People with PCD have extremely low levels of nitric oxide in the nasal passages, and measuring this gas is recommended as a first-line screening test in cooperative patients aged five and older.16PubMed Central. Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia – Section: Abstract A result above the cutoff makes PCD unlikely and can spare the patient more invasive workup, while a persistently low result justifies proceeding to confirmatory tests.17PubMed Central. The utility of nasal nitric oxide in the diagnostic evaluation of primary ciliary dyskinesia – Section: CONCLUSION
Confirmatory testing traditionally relied on transmission electron microscopy (TEM), which lets pathologists directly see whether the internal structure of cilia looks normal. But TEM is slow, expensive, and misses certain genetic forms of PCD where the structure looks fine under the microscope even though the cilia don’t beat properly. High-speed video microscopy (HSVM) offers a functional complement by recording how cilia actually beat, though the technique is sensitive to how samples are handled. Ciliary beat patterns can become artificially dyskinetic as samples sit at room temperature, so labs need to analyze specimens promptly to avoid false results.18PubMed Central. High-Speed Video Microscopy for Primary Ciliary Dyskinesia Diagnosis: A Study of Ciliary Motility Variations with Time and Temperature
Immunofluorescence staining has emerged as a faster and cheaper alternative to electron microscopy. In a diagnostic study, this technique correctly identified the disorder in 22 of 25 confirmed PCD patients, returned normal results in all 252 people considered unlikely to have PCD, and resolved over half of previously inconclusive cases. Results were available within two weeks at a cost of about $187 per sample, compared with nearly a month and about $1,452 for electron microscopy.19PubMed Central. Accuracy of Immunofluorescence in the Diagnosis of Primary Ciliary Dyskinesia Genetic panel testing rounds out the diagnostic toolkit, particularly when other tests are inconclusive or when identifying the exact mutation matters for family planning or eligibility for emerging therapies.
Acquired Ciliary Dyskinesia
Not all ciliary dysfunction is genetic. Chronic inflammation from infections, cigarette smoke, air pollution, and other inhaled irritants can damage or destroy cilia in the airway lining, producing a condition sometimes called secondary or acquired ciliary dyskinesia.20Termedia Publishing. Chronic inflammation in the respiratory tract and ciliary dyskinesia Unlike PCD, this form is usually patchy rather than universal, affecting only the regions exposed to the insult. It can sometimes be reversible if the underlying irritant is removed and the epithelium regenerates. This distinction matters clinically because acquired ciliary damage can mimic PCD on a nasal biopsy, leading to misdiagnosis if the sample happens to come from an inflamed area. Diagnostic guidelines generally recommend collecting samples during a period when the patient is free of acute infection to minimize this confounding factor.
Day-to-Day Management
There is currently no cure for PCD. Treatment focuses on keeping the airways as clear as possible and treating infections aggressively when they occur. In a natural history study of children with PCD, virtually all received at least one course of antibiotics during the study period, with cephalosporins and amoxicillin-clavulanate being the most commonly prescribed.21PubMed Central. Therapies used by children with primary ciliary dyskinesia: A natural history study – Section: Results As patients age and their airways become colonized with harder-to-treat bacteria like Pseudomonas, the antibiotic regimen often escalates to include inhaled aminoglycosides and fluoroquinolones. About a third of children in the same study used chronic azithromycin, a strategy borrowed from cystic fibrosis care that aims to reduce airway inflammation as much as fight bacteria directly.
Airway clearance techniques are a daily obligation. Exercise, high-frequency chest wall oscillation vests, and positive expiratory pressure devices were the most commonly used methods.22PubMed Central. Therapies used by children with primary ciliary dyskinesia: A natural history study – Section: Results Inhaled hypertonic saline and dornase alfa, which thin mucus, were used by a substantial minority. Bronchodilators and inhaled corticosteroids are also widely prescribed, though a recent review noted that many of these additional therapies lack robust evidence specifically supporting their use in PCD and are largely carried over from cystic fibrosis protocols.23PubMed. Treatment of Lung Disease in Primary Ciliary Dyskinesia: A Review of Current and Emerging Interventions The PCD community is still relatively small compared with cystic fibrosis, which means clinical trials dedicated to PCD have historically been scarce, and clinicians often extrapolate from CF data in the absence of PCD-specific evidence.
Living with PCD
The daily treatment burden is substantial, and patients describe it in blunt terms. Adults participating in the development of a PCD-specific quality-of-life questionnaire spoke about airway clearance routines as tedious but unavoidable: one said, “I don’t really want to do it; it’s kind of boring and it’s not fun and I’d rather do something else. But obviously you have to do it.”24PubMed Central. A quality-of-life measure for adults with primary ciliary dyskinesia: QOL–PCD – Section: Results Others emphasized the planning overhead: waking up earlier, coming home from work to do treatments, rearranging social life around a daily medical routine. A systematic review of patient experience literature confirmed that the burden of treatment and factors influencing adherence were among the most frequently discussed themes.25PubMed Central. The patient’s experience of primary ciliary dyskinesia: a systematic review – Section: RESULTS
Social and emotional effects pile on top of the physical ones. The chronic wet cough can be socially isolating, especially in school-age children who are old enough to feel self-conscious. Repeated absences from school or work for infections or clinic appointments disrupt normal routines. And the relative obscurity of PCD means that patients often feel unheard: teachers, employers, and even some healthcare providers have never encountered the condition and may underestimate its seriousness.
Gene Therapy and mRNA on the Horizon
The most exciting development for PCD in recent years is the prospect of a treatment that actually addresses the root cause rather than just managing symptoms. Because PCD results from a missing or broken protein in the ciliary machinery, delivering a working copy of the relevant gene or its messenger RNA to airway cells could, in theory, restore normal ciliary beating. A research group has demonstrated that lipid nanoparticle-encapsulated mRNA encoding the DNAI1 protein, one of the commonly mutated outer dynein arm components, can be delivered by aerosol inhalation. In mouse studies, the mRNA reached the ciliated cells of the lower airways and was translated into functional human DNAI1 protein, and in a cell-based PCD model, the treatment rescued ciliary beat frequency.26PubMed. Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia
That work has since moved into nonhuman primates, where aerosolized delivery of the same mRNA construct produced detectable levels of human DNAI1 protein in the lungs at doses overlapping with those that restored ciliary function in the cell model.27PubMed Central. Inhaled DNAI1 mRNA therapy for treatment of primary ciliary dyskinesia These results support moving the therapy into human clinical trials, though substantial hurdles remain. The mRNA effect is temporary, so patients would likely need repeated inhalation treatments, perhaps weekly or monthly. And because PCD involves so many different genes, an mRNA therapy designed for DNAI1 mutations would not help patients whose disease stems from a different gene. Broader gene therapy strategies, including viral vector delivery and gene editing approaches, are also being explored.28PubMed. Restoring Ciliary Function: Gene Therapeutics for Primary Ciliary Dyskinesia None of these are ready for the clinic yet, but after decades with nothing beyond symptom management, the field has genuine reasons for optimism.
PCD Versus Other Ciliopathies
PCD is sometimes lumped together with a broader family of diseases called ciliopathies, but the distinction matters. PCD specifically involves motile cilia, the kind that beat to move fluid. Other ciliopathies involve non-motile (primary) cilia, which don’t beat at all but instead act as cellular antennae, picking up chemical signals from the cell’s environment. Defects in these sensory cilia cause a completely different set of diseases, including polycystic kidney disease, certain forms of retinal degeneration, and skeletal abnormalities.29PubMed Central. Understanding Primary Ciliary Dyskinesia and Other Ciliopathies A person with PCD does not, for instance, face an increased risk of kidney cysts simply because their disorder has “ciliary” in the name. The two categories share evolutionary ancestry and some overlapping protein components, but they are clinically distinct conditions with different symptoms, different affected organs, and different management strategies.